The biotechnology company focused on researching and discovering new and effective treatments for psychiatric and neurological disorders, Pasithea Therapeutics, is partnering with The Glimpse Group, a VR and AR platform company, and its subsidiary, Foretell Reality.

Foretell Reality specializes in VR applications for mental health therapy, support, and human interaction.

“We are thrilled to partner with Glimpse to bring VR and AR to patients suffering from mental health disorders. Among its many benefits, VR unites a patient and therapist in a shared environment, which is particularly important in situations where the therapist is remote, such as with our at-home treatment model,” said Dr. Tiago Reis Marques, CEO of Pasithea Therapeutics.

“VR can also create scenarios to reflect specific traumatic experiences or simulate emotionally loaded conversations. VR is increasingly becoming an innovative clinical tool for patients with specific psychiatric symptoms, which leads to improved patient outcomes, and we look forward to co-developing the program alongside Glimpse,” he added.

The two companies aim to jointly develop VR environments that aid in the treatment of patients with psychiatric disorders more effectively.

Lyron Bentovim, President and CEO of Glimpse, said, “VR technology is becoming widely adopted in the healthcare industry, with a range of applications including mental health and psychological therapies, pain management, and robotic surgery. Glimpse, through its base of subsidiary companies, has direct experience in developing such solutions with leading companies, hospitals, and universities in the segment. We look forward to our collaboration with Pasithea.”

Follow us on LinkedIn

Read other Articles